Vulnerability
Atril Document Viewer is the default document reader of the MATE desktop environment for Linux. A single-click remote code execution vulnerability in versions prior to 1.26.3 and 1.28.4 allows an attacker to achieve arbitrary code execution
Atril Document Viewer is the default document reader of the MATE desktop environment for Linux. A single-click remote code execution vulnerability in versions prior to 1.26.3 and 1.28.4 allows an attacker to achieve arbitrary code execution as the user by tricking them into clicking a link inside a malicious PDF document. The PDF can be packaged as a polyglot file that is simultaneously a valid PDF and a valid ELF shared library, making the attack a single-file, single-click, configuration-independent RCE on stock atril installations. The root cause is `shell/ev-application.c:ev_spawn`, which builds a command line from attacker-controlled PDF link-destination fields without applying `g_shell_quote`. The cmdline is then handed to `g_app_info_create_from_commandline`, which shell-parses it back into argv — splitting any embedded `--gtk-module=PATH` into a separate argv element. GTK then `dlopen()`s the path during init, running any `__attribute__((constructor))` it finds. Versions 1.26.3 and 1.28.4 contain a patch for the issue. This is the same defect class as CVE-2023-51698 (CBT `--checkpoint-action` injection in `comics-document.c`, fixed in 1.6.2) but in a different code path (`shell/ev-application.c`) that the original patch did not touch.
No CVSS base score from NVD or GHSA yet. NVD typically scores within 24–72 hours of publication; GHSA usually within a day for OSS-flagged CVEs. Last record update .
For interim severity, fall back on KEV / EXPLOIT signals and the EPSS percentile (lower panel). Re-check this CVE after one cron tick — the score lands automatically when the source publishes.
Low exploitation likelihood — defer if no other signals fire.
No VEX statements published for CVE-2026-46529. Vendors publish VEX (Vulnerability Exploitability eXchange) to assert per-product whether a CVE is actually exploitable in their distribution.
No exploitation, limited impact or prevalence